{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:58:54Z","timestamp":1788994734697,"version":"build-2803163510"},"reference-count":127,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Psoriasis is a chronic, systemic, immune-mediated inflammatory disorder that is associated with a significantly increased risk of cardiovascular disease (CVD). Studies have shown that psoriasis often coexists with atherosclerosis, a chronic inflammatory disease of large and medium-sized arteries, which is a major cause of CVD. Although the molecular mechanisms underlying this comorbidity are not fully understood, clinical studies have shown that when interleukin (IL)-17A inhibitors effectively improve psoriatic lesions, atherosclerotic symptoms are also ameliorated in patients with both psoriasis and atherosclerosis. Also, IL-17A levels are highly expressed in the psoriatic lesions and atherosclerotic plaques. These clinical observations implicit that IL-17A could be a crucial link for psoriasis and atherosclerosis and IL-17A-induced inflammatory responses are the major contribution to the pathogenesis of comorbid psoriasis and atherosclerosis. In this review, the current literature related to epidemiology, genetic predisposition, and inflammatory mechanisms of comorbidity of psoriasis and atherosclerosis is summarized. We focus on the immunopathological effects of IL-17A in both diseases. The goal of this review is to provide the theoretical base for future preventing or treating psoriasis patients with atherosclerosis comorbidity. The current evidence support the notion that treatments targeting IL-17 seem to be hold some promise to reduce cardiovascular risk in patients with psoriasis.<\/jats:p>","DOI":"10.3389\/fimmu.2022.835671","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T11:40:18Z","timestamp":1650368418000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Interleukin-17 Links Inflammatory Cross-Talks Between Comorbid Psoriasis and Atherosclerosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongrui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14335","article-title":"Interleukin-9 Serves as a Key Link Between Systemic Inflammation and Angiogenesis in Psoriasis","volume":"46","author":"Midde","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis Pathogenesis and Treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/168321","article-title":"Lifting the Silver Flakes: The Pathogenesis and Management of Chronic Plaque Psoriasis","volume":"2013","author":"Chong","year":"2013","journal-title":"BioMed Res Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.040","article-title":"Interleukin 17, Inflammation, and Cardiovascular Risk in Patients With Psoriasis","volume":"79","author":"Lockshin","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50591","article-title":"Beyond Skin Deep: Addressing Comorbidities in Psoriasis","volume":"212","author":"Kovitwanichkanont","year":"2020","journal-title":"Med J Aust"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","article-title":"The Concept of Psoriasis as a Systemic Inflammation: Implications for Disease Management","author":"Reich","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12024","article-title":"Clinical Practice Guideline for an Integrated Approach to Comorbidity in Patients With Psoriasis","volume":"27","author":"Dauden","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/08830185.2018.1539084","article-title":"Psoriasis and Cardiovascular Disease: The Elusive Link","volume":"38","author":"Manolis","year":"2019","journal-title":"Int Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1109\/TCBB.2016.2550443","article-title":"PCID: A Novel Approach for Predicting Disease Comorbidity by Integrating Multi-Scale Data","volume":"14","author":"He","year":"2017","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41569-021-00668-4","article-title":"Therapeutic Strategies Targeting Inflammation and Immunity in Atherosclerosis: How to Proceed","author":"Engelen","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00584-1","article-title":"How the Immune System Shapes Atherosclerosis: Roles of Innate and Adaptive Immunity","volume":"22","author":"Roy","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14180","article-title":"Effect of Biologics Targeting Interleukin-23\/-17 Axis on Subclinical Atherosclerosis: Results of a Pilot Study","volume":"45","author":"Marovt","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.10.042","article-title":"Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients Over 52 Weeks","volume":"139","author":"von Stebut","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2174\/0929867326666190903112146","article-title":"Endothelial Dysfunction in Dyslipidaemia: Molecular Mechanisms and Clinical Implications","volume":"27","author":"Zaric","year":"2020","journal-title":"Curr Med Chem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12101","article-title":"The Association Between Psoriasis and Dyslipidaemia: A Systematic Review","volume":"168","author":"Ma","year":"2013","journal-title":"Br J Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16273","article-title":"The Role of the Interleukin-23\/Th17 Pathway in Cardiometabolic Comorbidity Associated With Psoriasis","volume":"34","author":"Egeberg","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00117","article-title":"Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities","volume":"11","author":"Gisondi","year":"2020","journal-title":"Front Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"535612","DOI":"10.1155\/2010\/535612","article-title":"Lipid Disturbances in Psoriasis: An Update","volume":"2010","author":"Pietrzak","year":"2010","journal-title":"Mediators Inflamm"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_717_16","article-title":"Dyslipidaemia & Oxidative Stress in Patients of Psoriasis: Emerging Cardiovascular Risk Factors","volume":"146","author":"Asha","year":"2017","journal-title":"Indian J Med Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.11.025","article-title":"Coronary Artery Disease in Patients With Psoriasis Referred for Coronary Angiography","volume":"109","author":"Armstrong","year":"2012","journal-title":"Am J Cardiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.03.028","article-title":"Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events","volume":"124","author":"Mehta","year":"2011","journal-title":"Am J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.05.016","article-title":"The Impact of Psoriasis on 10-Year Framingham Risk","volume":"67","author":"Mehta","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/0003319716652284","article-title":"Assessment of Arterial Stiffness in Korean Patients With Psoriasis by Cardio-Ankle Vascular Index","volume":"68","author":"Choi","year":"2017","journal-title":"Angiology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1177\/1203475415602842","article-title":"Psoriasis as an Independent Risk Factor for Cardiovascular Disease: An Epidemiologic Analysis Using a National Database","volume":"20","author":"Lai","year":"2016","journal-title":"J Cutan Med Surg"},{"key":"B27","article-title":"Atherosclerosis: Process, Indicators, Risk Factors and New Hopes","volume":"5","author":"Rafieian-Kopaei.","year":"2014","journal-title":"Int J Prev Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.3390\/ijms20184347","article-title":"Risk Factors for the Development of Psoriasis","volume":"20","author":"Kamiya","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/2047487319869400","article-title":"Lifestyle Factors and High-Risk Atherosclerosis: Pathways and Mechanisms Beyond Traditional Risk Factors","volume":"27","author":"Lechner","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08780.x","article-title":"Inflammation in Atherosclerosis and Psoriasis: Common Pathogenic Mechanisms and the Potential for an Integrated Treatment Approach","author":"Spah","year":"2008","journal-title":"Br J Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2010.01.002","article-title":"Comorbidities in Psoriasis Patients","volume":"29","author":"Kim","year":"2010","journal-title":"Semin Cutan Med Surg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(09)60318-4","article-title":"Body-Mass Index and Cause-Specific Mortality in 900\u2008000 Adults: Collaborative Analyses of 57 Prospective Studies","volume":"373","author":"Prospective Studies","year":"2009","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001474","article-title":"The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis","volume":"10","author":"Fall","year":"2013","journal-title":"PloS Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes","volume":"369","author":"Look","year":"2013","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv012","article-title":"Blood Pressure in Relation to General and Central Adiposity Among 500 000 Adult Chinese Men and Women","volume":"44","author":"Chen","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15046184","article-title":"Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship Between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease","volume":"15","author":"Jung","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/nu5041218","article-title":"Dyslipidemia in Obesity: Mechanisms and Potential Targets","volume":"5","author":"Klop","year":"2013","journal-title":"Nutrients"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and Metabolic Syndrome: A Systematic Review and Meta-Analysis of Observational Studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.008097","article-title":"Organizational Update: The World Health Organization Global Status Report on Noncommunicable Diseases 2014; One More Landmark Step in the Combat Against Stroke and Vascular Disease","volume":"46","author":"Mendis","year":"2015","journal-title":"Stroke"},{"key":"B40","doi-asserted-by":"publisher","first-page":"WC01","DOI":"10.7860\/JCDR\/2016\/17791.7218","article-title":"Prevalence of Metabolic Syndrome in Psoriasis Patients and its Relation to Disease Duration: A Hospital Based Case-Control Study","volume":"10","author":"Praveenkumar","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3390\/nu11092195","article-title":"Adiponectin Expression and Genotypes in Italian People With Severe Obesity Undergone a Hypocaloric Diet and Physical Exercise Program","volume":"11","author":"Corbi","year":"2019","journal-title":"Nutrients"},{"key":"B42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/metabo10010032","article-title":"Adipokines and Adipose Tissue-Related Metabolites, Nuts and Cardiovascular Disease","volume":"10","author":"Weschenfelder","year":"2020","journal-title":"Metabolites"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.3390\/ijms21103570","article-title":"Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications","volume":"21","author":"Zorena","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1038\/ncomms8687","article-title":"Adiponectin Regulates Psoriasiform Skin Inflammation by Suppressing IL-17 Production From Gammadelta-T Cells","volume":"6","author":"Shibata","year":"2015","journal-title":"Nat Commun"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.5114\/pdia.2014.40960","article-title":"Effect of Psoriasis Activity on Serum Adiponectin and Leptin Levels","volume":"32","author":"Baran","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.366","article-title":"Association of Cardiovascular and Metabolic Disease Genes With Psoriasis","volume":"133","author":"Lu","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.667690","article-title":"Exploring the Pathogenesis of Psoriasis Complicated With Atherosclerosis via Microarray Data Analysis","volume":"12","author":"Su","year":"2021","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2939658","article-title":"Doxycycline Inhibits IL-17-Stimulated MMP-9 Expression by Downregulating ERK1\/2 Activation: Implications in Myogenic Differentiation","volume":"2016","author":"Obradovic","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S125595","article-title":"Narrowband Ultraviolet B Light Treatment Changes Plasma Concentrations of MMP-3, MMP-9 and TIMP-3 in Psoriatic Patients","volume":"13","author":"Glazewska","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"B50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3892\/ijmm.2019.4392","article-title":"Prediction of Crucial Epigeneticallyassociated, Differentially Expressed Genes by Integrated Bioinformatics Analysis and the Identification of S100A9 as a Novel Biomarker in Psoriasis","volume":"45","author":"Wang","year":"2020","journal-title":"Int J Mol Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594735","article-title":"The IL-23\/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102576","article-title":"Life Before Seventeen: Cloning of the IL-17 Receptor","volume":"187","author":"Gaffen","year":"2011","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2011.07.006","article-title":"Recent Advances in the IL-17 Cytokine Family","volume":"23","author":"Gaffen","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.jid.2019.01.021","article-title":"IL-17e (IL-25) Enhances Innate Immune Responses During Skin Inflammation","volume":"139","author":"Senra","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.65","article-title":"Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis","volume":"129","author":"Harper","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/ni1497","article-title":"Development, Cytokine Profile and Function of Human Interleukin 17-Producing Helper T Cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/bjd.14703","article-title":"The Many Faces of Interleukin-17 in Inflammatory Skin Diseases","volume":"175","author":"Speeckaert","year":"2016","journal-title":"Br J Dermatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-017-0094-4","article-title":"Ultra-Sensitive Measurement of IL-17A and IL-17F in Psoriasis Patient Serum and Skin","volume":"19","author":"Soderstrom","year":"2017","journal-title":"AAPS J"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.01.036","article-title":"Neutralization of IL-17c Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis","volume":"138","author":"Vandeghinste","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.307892","article-title":"Smooth Muscle Cell-Derived Interleukin-17c Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17a+ T Cells to the Aorta","volume":"36","author":"Butcher","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.06.009","article-title":"Keratinocyte-Derived IL-17e Contributes to Inflammation in Psoriasis","volume":"136","author":"Senra","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.jaci.2017.12.1007","article-title":"IL-25 Enhances TH17 Cell-Mediated Contact Dermatitis by Promoting IL-1beta Production by Dermal Dendritic Cells","volume":"142","author":"Suto","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA117.000292","article-title":"Interleukin-25 (IL-25) has a Protective Role in Atherosclerosis Development in the Aortic Arch in Mice","volume":"293","author":"Mantani","year":"2018","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117255","article-title":"IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice","volume":"10","author":"Mantani","year":"2015","journal-title":"PloS One"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08902.x","article-title":"Characterization of the Interleukin-17 Isoforms and Receptors in Lesional Psoriatic Skin","volume":"160","author":"Johansen","year":"2009","journal-title":"Br J Dermatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01682","article-title":"The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond","volume":"9","author":"Brembilla","year":"2018","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/ijms21041275","article-title":"Interleukin-17A and Keratinocytes in Psoriasis","volume":"21","author":"Furue","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00579","article-title":"Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences","volume":"9","author":"Boehncke","year":"2018","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12142","article-title":"Interleukin-17A: A Unique Pathway in Immune-Mediated Diseases: Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis","volume":"141","author":"Kirkham","year":"2014","journal-title":"Immunology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.immuni.2019.05.004","article-title":"The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17 Cells","volume":"51","author":"Omenetti","year":"2019","journal-title":"Immunity"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1783","article-title":"Thymic Self-Reactivity Selects Natural Interleukin 17-Producing T Cells That can Regulate Peripheral Inflammation","volume":"10","author":"Marks","year":"2009","journal-title":"Nat Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.146","article-title":"Composition of Innate Lymphoid Cell Subsets in the Human Skin: Enrichment of NCR(+) ILC3 in Lesional Skin and Blood of Psoriasis Patients","volume":"134","author":"Teunissen","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2012.10.003","article-title":"Innate Lymphoid Cells: Balancing Immunity, Inflammation, and Tissue Repair in the Intestine","volume":"12","author":"Tait Wojno","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.05.001","article-title":"Plasticity of CD4+ T Cell Lineage Differentiation","volume":"30","author":"Zhou","year":"2009","journal-title":"Immunity"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-10-246660","article-title":"Elevated IL-17 Produced by TH17 Cells Promotes Myeloma Cell Growth and Inhibits Immune Function in Multiple Myeloma","volume":"115","author":"Prabhala","year":"2010","journal-title":"Blood"},{"key":"B77","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal Role of Dermal IL-17-Producing Gammadelta T Cells in Skin Inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-011-0700-z","article-title":"Regulation and Function of IL-17A- and IL-22-Producing Gammadelta T Cells","volume":"68","author":"Ness-Schwickerath","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15358","article-title":"IL-17A Localizes in the Exocytic Compartment of Mast Cells in Psoriatic Skin","volume":"177","author":"Brembilla","year":"2017","journal-title":"Br J Dermatol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12467","article-title":"Psoriasis-Like Inflammation Induced in an Air-Pouch Mouse Model","volume":"35","author":"Charitidis","year":"2021","journal-title":"In Vivo"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice is Mediated via the IL-23\/IL-17 Axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13466","article-title":"IL-12 Protects From Psoriasiform Skin Inflammation","volume":"7","author":"Kulig","year":"2016","journal-title":"Nat Commun"},{"key":"B83","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jaci.2010.12.009","article-title":"Human Slan (6-Sulfo LacNAc) Dendritic Cells are Inflammatory Dermal Dendritic Cells in Psoriasis and Drive Strong TH17\/TH1 T-Cell Responses","volume":"127","author":"Hansel","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1155\/MI.2005.273","article-title":"Serum Levels of TNF-Alpha, IFN-Gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in Patients With Active Psoriasis and Correlation With Disease Severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediators Inflamm"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2011.01308.x","article-title":"A Tale of Two Plaques: Convergent Mechanisms of T-Cell-Mediated Inflammation in Psoriasis and Atherosclerosis","volume":"20","author":"Armstrong","year":"2011","journal-title":"Exp Dermatol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"75","DOI":"10.12988\/asms.2013.13008","article-title":"Factors Involved in the Pathogenesis of Psoriasis","volume":"1","author":"Abdelnoor","year":"2013","journal-title":"Adv Stud Med Sci"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1461","article-title":"Interleukin-17 Promotes Angiogenesis and Tumor Growth","volume":"101","author":"Numasaki","year":"2003","journal-title":"Blood"},{"key":"B88","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.imlet.2004.01.014","article-title":"Interleukin-17 Augments Tumor Necrosis Factor-Alpha-Induced Elaboration of Proangiogenic Factors From Fibroblasts","volume":"93","author":"Numasaki","year":"2004","journal-title":"Immunol Lett"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2014.01.012","article-title":"Interleukin-17A in Lipid Metabolism and Atherosclerosis","volume":"431","author":"Yu","year":"2014","journal-title":"Clin Chim Acta"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00268-12","article-title":"TRAF6-Dependent Act1 Phosphorylation by the IkappaB Kinase-Related Kinases Suppresses Interleukin-17-Induced NF-kappaB Activation","volume":"32","author":"Qu","year":"2012","journal-title":"Mol Cell Biol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.303567","article-title":"IL-17 and Th17 Cells in Atherosclerosis: Subtle and Contextual Roles","volume":"35","author":"Taleb","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/cvr\/cvx225","article-title":"IL-17 in Atherosclerosis: The Good and the Bad","volume":"114","author":"Taleb","year":"2018","journal-title":"Cardiovasc Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1993","article-title":"Fate Mapping of IL-17-Producing T Cells in Inflammatory Responses","volume":"12","author":"Hirota","year":"2011","journal-title":"Nat Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2416","article-title":"Induction and Molecular Signature of Pathogenic TH17 Cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.12.026","article-title":"Correlation of Peripheral Th17 Cells and Th17-Associated Cytokines to the Severity of Carotid Artery Plaque and its Clinical Implication","volume":"221","author":"Liu","year":"2012","journal-title":"Atherosclerosis"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and Interferon-Gamma Are Produced Concomitantly by Human Coronary Artery-Infiltrating T Cells and Act Synergistically on Vascular Smooth Muscle Cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"B97","doi-asserted-by":"publisher","first-page":"13831","DOI":"10.1038\/s41598-017-14365-1","article-title":"IFN-Gamma and TNF-Alpha Synergism may Provide a Link Between Psoriasis and Inflammatory Atherogenesis","volume":"7","author":"Mehta","year":"2017","journal-title":"Sci Rep"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.07.110","article-title":"The Pleiotropic Role of Interleukin-17 in Atherosclerosis","volume":"106","author":"Allam","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2817","article-title":"IL-23 Induces Spondyloarthropathy by Acting on ROR-Gammat+ CD3+CD4-CD8- Entheseal Resident T Cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101712","article-title":"IL-23-Responsive Innate Lymphoid Cells are Increased in Inflammatory Bowel Disease","volume":"208","author":"Geremia","year":"2011","journal-title":"J Exp Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and Inflammation in Atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/ni1539","article-title":"TGF-\u03b2 and IL-6 Drive the Production of IL-17 and IL-10 by T Cells and Restrain TH-17 Cell\u2013Mediated Pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.36660\/ijcs.20200021","article-title":"Psoriatic March, Skin Inflammation and Cardiovascular Events \u2013 Two Plaques for One Syndrome","volume":"33","author":"Boechat","year":"2020","journal-title":"Int J Cardiovasc Sci"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr425","article-title":"Psoriasis and Atherosclerosis: Two Plaques, One Syndrome","volume":"33","author":"Flammer","year":"2012","journal-title":"Eur Heart J"},{"key":"B105","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cyto.2013.03.013","article-title":"IL-17 in Psoriasis: Implications for Therapy and Cardiovascular Co-Morbidities","volume":"62","author":"Golden","year":"2013","journal-title":"Cytokine"},{"key":"B106","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/jid.2012.194","article-title":"The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings","volume":"133","author":"Martin","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jaci.2009.08.046","article-title":"Effective Treatment of Psoriasis With Etanercept is Linked to Suppression of IL-17 Signaling, Not Immediate Response TNF Genes","volume":"124","author":"Zaba","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 Family of Cytokines in Health and Disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"B109","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1517\/13543784.2013.806483","article-title":"IL-17 Targeted Therapies for Psoriasis","volume":"22","author":"Chiricozzi","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.340","article-title":"Integrative Responses to IL-17 and TNF-Alpha in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2001","article-title":"The Immune System in Atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8702-3","article-title":"The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.03.009","article-title":"Regulation of IL-17 in Atherosclerosis and Related Autoimmunity","volume":"74","author":"Ryu","year":"2015","journal-title":"Cytokine"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-014-0098-x","article-title":"The Role of Interleukin-17A in Psoriatic Disease","volume":"28","author":"Adami","year":"2014","journal-title":"BioDrugs"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)31429-0","article-title":"Ixekizumab for the Treatment of Patients With Active Psoriatic Arthritis and an Inadequate Response to Tumour Necrosis Factor Inhibitors: Results From the 24-Week Randomised, Double-Blind, Placebo-Controlled Period of the SPIRIT-P2 Phase 3 Trial","volume":"389","author":"Nash","year":"2017","journal-title":"Lancet"},{"key":"B116","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13075-019-1882-2","article-title":"Long-Term Safety of Secukinumab in Patients With Moderate-to-Severe Plaque Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis: Integrated Pooled Clinical Trial and Post-Marketing Surveillance Data","volume":"21","author":"Deodhar","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis Pathogenesis and the Development of Novel Targeted Immune Therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in Atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.3390\/ijms18102034","article-title":"New Insights Into the Role of Inflammation in the Pathogenesis of Atherosclerosis","volume":"18","author":"Wu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, Atherosclerosis, and Coronary Artery Disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12406","article-title":"Inflammation and Plaque Vulnerability","volume":"278","author":"Hansson","year":"2015","journal-title":"J Intern Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14712598.2019.1555235","article-title":"Anti-IL17 Therapies for Psoriasis","volume":"19","author":"Silfvast-Kaiser","year":"2019","journal-title":"Expert Opin Biol Ther"},{"key":"B123","article-title":"Actual Treatments of Psoriasis : From Etanercept to Anti-IL17 and Anti-IL23 Antagonists","volume":"75","author":"Libon","year":"2020","journal-title":"Rev Med Liege"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.304108","article-title":"Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease","volume":"34","author":"Karbach","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.jid.2020.01.025","article-title":"A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)","volume":"140","author":"Gelfand","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.09.021","article-title":"Protection From Psoriasis-Related Thrombosis After Inhibition of IL-23 or IL-17a","volume":"138","author":"Li","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The Effects of Tumour Necrosis Factor Inhibitors, Methotrexate, non-Steroidal Anti-Inflammatory Drugs and Corticosteroids on Cardiovascular Events in Rheumatoid Arthritis, Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-Analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.835671\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T11:40:24Z","timestamp":1650368424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.835671\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":127,"alternative-id":["10.3389\/fimmu.2022.835671"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.835671","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]},"article-number":"835671"}}